23 employees
Rectify Pharmaceuticals is a biotechnology company developing Positive Functional Modulators (PFMs), disease-modifying therapeutics.
2020
$100M
from 4 investors over 4 rounds
Rectify Pharma raised $100M on October 14, 2021
Investors: Omega Funds, Atlas Venture, Longwood Fund and Forbion